Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
Tuesday, July 02, 2024Kashiv BioSciences LLC today announced that it has entered into an exclusive licensing agreement for ADL a proposed biosimilar to omalizumab referencing
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy
Tuesday, July 02, 2024Ovid Therapeutics Inc a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies
Biophytis Presented Its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris
Monday, July 01, 2024Biophytis SA a clinicalstage biotechnology company specialized in the development of therapeutics for agerelated diseases presented the rollout and results of its phase COVA
Idorsia’s JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertension
Monday, July 01, 2024Idorsia Ltd announced today that the European Commission has approved JERAYGO for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products
CHMP Recommends EU Approval of Roche’s Piasky for People With PNH, a Rare, Life-threatening Blood Condition
Saturday, June 29, 2024Roche announced today that the European Medicines Agencys Committee for Medicinal Products for Human Use has adopted a positive opinion for PiaSky for the treatment of paroxysmal nocturnal haemoglobinuria
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
Saturday, June 29, 2024Regeneron Pharmaceuticals Inc today announced that the European Medicines Agencys Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional marketing
Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)
Saturday, June 29, 2024Merck known as MSD outside of the United States and Canada announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the approval of WINREVAIR
GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a Personalizing, Gene Vector Immunotherapy, in Patients with Advanced Solid Tumors
Friday, June 28, 2024GenVivo Inc a private clinicalstage biopharmaceutical company with breakthrough offtheshelf platforms for cancer gene medicine immunotherapies announced
AbbVie Acquires Celsius Therapeutics
Friday, June 28, 2024AbbVie announced today the acquisition of Celsius Therapeutics Inc a privately held biotechnology company pioneering new therapies for patients with inflammatory disease Celsius lead investigational asset is CEL a potential firstinclass antiTREM anti...
Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
Thursday, June 27, 2024Harbour BioMed a global biopharmaceutical company committed to the discovery development and commercialization of novel antibody therapeutics focusing
